IL6 and Insulin resistance: At the same time, COVID-19 can activate the immune system, leading to the production of a range of cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), which induce insulin resistance and hyperglycemia (36).